United States Antimony Corporation Q3 2026 Earnings Recap

Shares fell 4.0% as investors reacted negatively to margin compression driven by rising costs, flat sales, and a cautious tone on near-term profitability despite operational progress.

Key Takeaways

• Q1 sales were essentially flat at $6.8 million versus $7 million year-over-year, with antimony sales down 2% and zeolite sales down 7%.
• Gross profit declined by $1.3 million due to higher labor, factory, import, and freight costs, which management attributed to investments in future production capacity.
• Net loss widened to $11.3 million, largely reflecting $4.8 million in noncash stock compensation and a $4.1 million unrealized loss on equity investments.
• Inventory increased significantly by $9.5 million to $22 million, indicating buildup for expected ramp-up later in the year.
• The company highlighted progress in securing mining permits and government grants but did not commit to near-term earnings improvement, underscoring ongoing operational risk ahead.